ATS
DXCM icon

Ashton Thomas Securities’s DexCom DXCM Stock Holding History

Ashton Thomas Securities’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,260
Closed -$84.5K – 491
2024
Q3 		$84.5K Sell
1,260
-6,537
-84% -$537K 0.02% 347
2024
Q2 		$864K Buy
+7,797
New +$986K 0.21% 115

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Ashton Thomas Securities's DXCM Position: Q4 2024 in Review

Ashton Thomas Securities sold out of DexCom (DXCM) in Q4 2024, closing a stake of 1,260 shares — an estimated $84.5K sold.

Ashton Thomas Securities first reported a position in DXCM in Q2 2024 and held it in 2 quarters. The position peaked at $864K in Q2 2024. 950 funds tracked by Wall St. Rank hold DXCM as of Q4 2024.

  • Ashton Thomas Securities reported no remaining DexCom position as of Q4 2024 after selling out during the quarter.
  • Ashton Thomas Securities sold 1,260 DexCom shares in Q4 2024, an estimated $84.5K.
  • Ashton Thomas Securities first reported a position in DexCom in Q2 2024 and held it in 2 quarters.
  • Ashton Thomas Securities's DexCom position peaked at $864K in Q2 2024.
  • 950 funds tracked by Wall St. Rank held DexCom as of Q4 2024.

Based on Ashton Thomas Securities's 13F filing for Q4 2024, filed 11 Feb 2025.